Prevalence of Osteoporosis in Liver Cirrhosis
Objective: The main aim of this study was to find the prevalence of osteoporosis in liver cirrhosis.
Place and duration of study: This study was carried out in Liver clinic or Mayo Hospital Lahore in a duration of 6 months from December 2018 to May 2019.
Materials and Methods: 50 patients were selected for the study. Both males and females were included in this study on random basis. Only those patients were selected who were willing to take part in this study. 40 to 70 years was the mean age and in all the patients either Hepatitis B or C was the reason for cirrhosis of liver. In all the patients DEXA scan was obtained and if the T value was less than 2.5 it was considered osteoporosis. Informed consent was taken from all the patients or their relatives.
Results: Among the selected 50 patients, 36% were females and 64% were male patients. 47 years was the mean age of the patients. Osteoporosis was found in 14 (28%) of the patients. 10 (31.25%) males were affected and it was greater than the percentage of female patients. Higher incidence was seen in patients with increasing age. Incidence was not related to the time duration for which the patient had cirrhosis.
Conclusion: Osteoporosis in case of liver cirrhosis is very common and every 4th or 5th patients with cirrhosis develops osteoporosis. It is usually neglected and considered insignificant. The complications increase with the increase in age.
Keywords: Osteoporosis, Cirrhosis, DEXA scan.
Runyon BA. A primer on detecting cirrhosis and caring for these patients without causing harm. Int J Hepatol. 2011;2011(1):801-83.
Mumtaz K, Ahmed US, Abid S. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20(8):514-18.
NakchbandiIA. Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. World J Gastroenterol. 2014;20(28):9427–38.
Jakobsen A, Laurberg P, Vestergaard P, Andersen S. Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland. Int J Circumpolar Health. 2013;72(8):01-07.
Yadav, A, CareyEJ. Osteoporosis in chronic liver disease. NutrClinPract. 2013;28:12-14.
Kaemmerer D, Schmidt B, Lehmann G, Wolf G, Settmacher U, Hommann M. Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation. Transplant Res. 2012;1(1):01-07.
Javed M,Saeed A,Khan IM,Hameed K,Rehman S,Khattak AK, et al. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases. J Ayub Med Coll Abbottabad.2009;21(3):51-3.
Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P. Osteoporosis in liver cirrhosis. Raomanian J Gastroenterol. 2005;14(4):337-41.
Gallego-Rojo FJ, Gonzalez-Calvin JL, MunozTorres M. Bone mineral density, serum insulin like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695–9.
Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004;10:648–53.
Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005;11:1843–7.
Isoniemi H, Appleberg J, Nilsson CG. Transdermal estrogen therapy protects postomenopausal liver transplant women from osteoporosis. A 2-year follow-up study.J Hepatol. 2001;34(2):299-305.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.